Jobs That Lower Alzheimer’s Risk
July 3, 2025
Carolyn Davis Talks About Her Leqembi Infusions
The newest and most promising drug to fight Alzheimer's is Leqembi. Carolyn Davis is giving it a try. Learn about the promise, the risks and how it has restored her hope, (Video)
Source:
Related:
Dementia Screening Test
May 21, 2025
Weight-loss Drug Ozempic Cuts Dementia Risk 48%
July 21, 2024
Making it Easier to Take Leqembi for Alzheimer’s
June 23, 2024
Should People with Alzheimer’s Avoid Resveratrol?
June 23, 2024
Email me when people comment
Login
0 Comments
Edited by:
Peter Berger
With experience in dementia caregiving, public education, and Alzheimer’s-focused writing—and a professional research background shaped in what many consider one of the world’s top laboratories—I work to make complex findings clear, practical, and genuinely helpful for families and professionals providing care.
Welcome. About this Site.
This site was inspired by my Mom’s autoimmune dementia.
It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. it has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.
The site is dedicated to all those preserving the dignity of the community of people living with dementia.
Peter Berger, Editor
Share this page To
Dementia Books & Videos on Amazon:
More From Alzheimer's Weekly
Clinical Trials
Levetiracetam Normalizes Alzheimer’s Brain Activity
DRUG RESEARCH VIDEO + ARTICLE: This FDA-approved anti-epileptic medication benefits Alzheimer’s in the lab. Learn about the promising research.
No Comments
Diagnosis
Think Well + Smell Well = Low Alzheimer’s Risk
DIAGNOSIS NEWS: Nearly all participants with mild memory problems who scored well on two 5-minute screening tests — measuring cognition and the ability to identify
No Comments
Drugs
Lecanemab Beats 3 Competing Antibodies
Why are some of the new anti-Alzheimer’s antibodies better than others? With the FDA’s approval of Lecanemab and Donanemab, it’s worth staying on top of this topic’s latest research.
No Comments
Advocacy
Dementia Alliance International – It’s About Human Rights
VIDEO: Kate Swaffer had to leave her job after she was diagnosed with dementia at the age of 49. See why she co-founded Dementia Awareness International, which is now giving a powerful voice to people with Dementia.
1 Comment
Share to Facebook
Twitter
LinkedIn
Welcome. About this Site.
This site was inspired by my Mom’s autoimmune dementia.
It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. it has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.
The site is dedicated to all those preserving the dignity of the community of people living with dementia.
Peter Berger, Editor
Visit Alzheimer's Weekly On